Lv4
550 积分 2025-04-25 加入
NEOADJUVANT CHEMOTHERAPY PLUS CADONILIMAB FOLLOWED BY FERTILITY-SPARING SURGERY IN YOUNG PATIENTS WITH CERVICAL CANCER: A PHASE II STUDY
1个月前
已关闭
The validity of the subsequent pregnancy index score for fertility-sparing trachelectomy in early-stage cervical cancer
1个月前
已完结
Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II
3个月前
已完结
The challenge of molecular stratification in No Specific Molecular Profile endometrial cancer
6个月前
已完结
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
7个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
7个月前
已完结
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma
7个月前
已关闭
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
7个月前
已完结
Hallmarks of cancer-Then and now, and beyond
7个月前
已完结
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025
9个月前
已完结
皖公网安备34019202002308
